Innoviva announced the creation of Nortiva Bio, a new entity that will build on Langer Lab assets rescued after the collapse of Lyndra Therapeutics. The company aims to develop long‑acting oral medicines and explore drug development alliances.
Noticias diarias26 ago 2026•3 min de lectura
Innoviva Forms Nortiva Bio to Advance Long‑Acting Oral Medicines
Innoviva has launched Nortiva Bio, using rescued Langer Lab assets to develop long‑acting oral medicines and seek drug development alliances.
Recopilado por el equipo de Pharmacountry · Fuente: FiercePharma
Temas:
Calificaciones
(0)
(0)
(0)
(0)
(0)
Deja tu valoración